← FDA Drug Approvals (Drugs@FDA)

LINZESS

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2012-08-30

Drug application

FDA Application #

NDA202811

Application type

New Drug Application

Brand name

LINZESS

Generic name

LINACLOTIDE

Active ingredients

LINACLOTIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2012-08-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown